References
- Kwan K. C. “Sustained and Controlled Release Drug Delivery Systems”, J. R. Robinson. Marcel Dekker inc. 1978; 595
- Welling P. G., Dobrinska M. R. “Controlled Drug Delivery. Fundamentals and Applications”, R. Robinson, V. H. Lee. Marcel Dekker Inc. 1987; 253
- Cutler D. J. Pharmacokin, Biopharm. 1978; 6: 265
- Gillespie W. R., Veng-Pedersen P. J. Pharmacokin. Biopharm. 1985; 13: 289
- Amdisen A. Clin. Pharmacokin. 1977; 2: 73
- Nielsen-Kudsk F., Amdisen A. Eur. J. Clin. Pharmacol. 1979; 16: 271
- Gaillot J., Steimer J. L., Mallet A. J., Thebault J. J. A. Bieder. J. Pharmacokin. Biopharm. 1979; 7: 579
- Davis J. M., Chang S. S., Pandey G. N., Musa M. N., Killion J. A. Clin. Pharmacol. Psychiatry 1981; 183
- Veng-Pedersen P. J. Pharm. Sci. 1980; 69: 312
- Mandallaz D., Mau J. Biometrics 1981; 37: 213
- Dixon W. J., Jennrich R. “BMDP Statistical Software”. University of California Press. 1981; 251
- USP XXI. United States Pharmacopeial Convention, Inc., Rockville, Md 1985
- Fariña J. B., Llabrés M. “Second European Congress of Biopharmaceutics and Pharmacokinetics”, J. M. Aiache, J. Hirtz, 1984; Vol. III: 134
- Fariña J. B., Llabrés M. S.T.P. Pharma 1987; 6: 505
- Ho N. F. H., Merkle H. P., Higuchi W. I. Drug Develop. & ind. Pharm. 1983; 9: 1111